Geron
GERN
#6280
Rank
A$1.25 B
Marketcap
A$1.97
Share price
3.15%
Change (1 day)
-68.04%
Change (1 year)

Geron (GERN) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.37 Billion

According to Geron's latest financial reports the company has A$0.37 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Geron - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.45 B23.83%
2023-12-31$A$0.36 B209.58%
2022-12-31$A$0.11 B-32.58%
2021-12-31$A$0.17 B-36.44%
2020-12-31$A$0.27 B42.11%
2019-12-31$A$0.19 B-23.49%
2018-12-31$A$0.25 B89.76%
2017-12-31$A$0.13 B-21.69%
2016-12-31$A$0.16 B-12.98%
2015-12-31$A$0.19 B22.15%
2014-12-31$A$0.15 B138.41%
2013-12-31$A$66.99 M-18.72%
2012-12-31$A$82.42 M-42.35%
2011-12-31$A$0.14 B-24.65%
2010-12-31$A$0.18 B-1.23%
2009-12-31$A$0.19 B-19.54%
2008-12-31$A$0.23 B1.5%
2007-12-31$A$0.23 B6.63%
2006-12-31$A$0.22 B-8.12%
2005-12-31$A$0.24 B52.23%
2004-12-31$A$0.15 B10.27%
2003-12-31$A$0.14 B170.97%
2002-12-31$A$52.78 M-56.22%
2001-12-31$A$0.12 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eterna Therapeutics
ERNA
A$5.37 M-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.30 B 8,527.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$2.95 B 690.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$7.00 B 1,770.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$38.16 Million-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA